Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
KMTS US Equity
KESTRA MEDICAL TECHNOLOGIES, LTD.
26.91USD▼ 0.26%
Healthcare
Medical Instruments & Supplies
96)Comparar97)Tesis →
Market Cap
$1.6B
Shares Outstanding
60M
Revenue (TTM)
$107M
Net Income (TTM)
−$150M
FCF (TTM)
−$123M
— Annual —FY2026
Revenue
$95M
Gross Margin
51.4%
Operating Margin
-141.6%
Net Margin
-138.4%
FCF Margin
-122.6%
ROE
-50.7%
ROCE
-43.7%
Net Debt/EBITDA
0.5×
Current Ratio
4.41
D/E Ratio
0.16
FCF / Share
-1.96
Book Value / Share
4.36
KMTS US Equity
26.91USD▼ 0.26%
Tesis →

KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS): análisis fundamental y valoración

KESTRA MEDICAL TECHNOLOGIES, LTD. cotiza a 26.91 USD y tiene una capitalización bursátil de $1.6B. En los últimos 12 meses ha facturado $107M con un margen de flujo de caja libre del -122.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNasdaqPaísUnited StatesEmpleados443Web↗ kestramedical.com

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Re…

Múltiplos de Valoración
P/E (Annual)
—
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
—
EV/Revenue
16.3×
P/Sales
16.9×
P/Book
6.2×
Rentabilidad (Último Anual)
Gross Margin
51.4%
Operating Margin
-141.6%
Net Margin
-138.4%
FCF Margin
-122.6%
ROE
-50.7%
ROCE
-43.7%
ROA
-36.7%
Effective Tax Rate
—
Métricas TTM
Revenue TTM
$107M
Gross Profit TTM
$58M
Operating Income TTM
−$144M
Net Income TTM
−$150M
FCF TTM
−$123M
EPS TTM
-2.68
Quarters Used
4
TTM Period
2025-10-31 → 2026-07-31
Solidez del Balance
Net Debt
−$57M
Net Debt / EBITDA
0.5×
Debt / Equity
0.16
Current Ratio
4.41
Interest Coverage
—
Working Capital
$172M
Book Value / Share
4.36
Net Debt / Share
-0.96
Crecimiento (YoY)
Revenue YoY
—
Net Income YoY
—
FCF YoY
—
EPS Diluted YoY
—
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
-1.96
CapEx % Revenue
36.7%
Rev / Employee
214,731
Próximos Eventos
Historial EPS
Periodo2026-122026-092026-072026-03
Real—$-0.46$-0.49$-0.40
Estimado$-0.60$-0.62$-0.58$-0.60
Sorpresa—+25.8%+15.5%+33.3%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaKMTSMediana SectorΔ
Gross Margin51.4%57.0%-5.7%
Operating Margin-141.6%-38.6%-103.0%
Net Margin-138.4%-33.6%-104.8%
FCF Margin-122.6%-13.9%-108.7%
ROE-50.7%-40.4%-10.3%
ROA-36.7%-32.0%-4.7%
Current Ratio4.412.84+1.57
Debt / Equity0.160.28-0.12
Scoring Fundamental
Piotroski F-Score
1/ 5Débil
✗F1ROA positivo (rentabilidad activos)
✗F2Flujo caja operativo positivo
✗F3ROA mejora vs año anterior
✓F4Calidad de beneficios (OCF > ROA)
✗F5Apalancamiento baja
✗F6Liquidez mejora (current ratio)
✗F7Sin dilución accionarial
✗F8Margen bruto mejora
✗F9Rotación activos mejora
Altman Z-ScoreZona Segura
6.79
x1_working_capital0.480
x2_retained_earnings-1.819
x3_ebit-0.376
x4_market_equity16.222
x5_sales0.265
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
3/ 8Débil
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✗DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos